Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
Aflibercept for Age-Related Macular Degeneration
Recruiting3 awardsPhase 4
Sherbrooke, Quebec
This trialwill study whether extending treatment intervals faster than standard T&E can maintain eye health and improve vision in patients with wet AMD.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.